Connection
David Badesch to Drug Approval
This is a "connection" page, showing publications David Badesch has written about Drug Approval.
|
|
Connection Strength |
|
|
|
|
|
0.031 |
|
|
|
-
Hill NS, Badesch D, Benza RL, D'Eletto TA, Farber HW, Gomberg-Maitland M, Hassoun PM, Preston I. Perspectives on oral pulmonary hypertension therapies recently approved by the U.S. Food and Drug Administration. Ann Am Thorac Soc. 2015 Feb; 12(2):269-73.
Score: 0.031